These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38954402)

  • 1. Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a
    Liao S; Teopiz KM; Kwan ATH; Le GH; Wong S; Ballum H; Rhee TG; Badulescu S; Cao B; Guo Z; Meshkat S; Phan L; Subramaniapillai M; Ho R; McIntyre RS
    Curr Med Res Opin; 2024 Jul; ():1-5. PubMed ID: 38954402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.
    Le GH; Kwan ATH; Wong S; Guo Z; Teopiz KM; Badulescu S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 Feb; 41(2):686-695. PubMed ID: 38114867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
    Badulescu S; Le GH; Wong S; Kwan ATH; Guo Z; Teopiz KM; Phan L; Subramaniapillai M; Rosenblat JD; Mansur RB; McIntyre RS
    Neurol Sci; 2024 Apr; 45(4):1335-1342. PubMed ID: 38321333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.
    Cao B; Park C; Subramaniapillai M; Lee Y; Iacobucci M; Mansur RB; Zuckerman H; Phan L; McIntyre RS
    Front Psychiatry; 2019; 10():17. PubMed ID: 30766492
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
    Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
    Kleine N; Kwan ATH; Le GH; Guo Z; Phan L; Subramaniapillai M; McIntyre RS
    CNS Spectr; 2024 Apr; 29(2):150-154. PubMed ID: 38453677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
    Kwan ATH; Guo Z; Ceban F; Le GH; Wong S; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; d'Andrea G; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 May; 41(5):1983-1994. PubMed ID: 38520501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder.
    Nakonezny PA; Morris DW; Greer TL; Byerly MJ; Carmody TJ; Grannemann BD; Bernstein IH; Trivedi MH
    J Psychiatr Res; 2015 Jun; 65():124-30. PubMed ID: 25864641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
    McIntyre RS; Phan L; Kwan ATH; Mansur RB; Rosenblat JD; Guo Z; Le GH; Lui LMW; Teopiz KM; Ceban F; Lee Y; Bailey J; Ramachandra R; Di Vincenzo J; Badulescu S; Gill H; Drzadzewski P; Subramaniapillai M
    Brain; 2024 Mar; 147(3):849-857. PubMed ID: 37936330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active versus sham DLPFC-NAc rTMS for depressed adolescents with anhedonia using resting-state functional magnetic resonance imaging (fMRI): a study protocol for a randomized placebo-controlled trial.
    Lv R; Cai M; Tang N; Shi Y; Zhang Y; Liu N; Han T; Zhang Y; Wang H
    Trials; 2024 Jan; 25(1):44. PubMed ID: 38218932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Anhedonia in Adults With and Without Mental Illness: A Systematic Review and Meta-analysis.
    Trøstheim M; Eikemo M; Meir R; Hansen I; Paul E; Kroll SL; Garland EL; Leknes S
    JAMA Netw Open; 2020 Aug; 3(8):e2013233. PubMed ID: 32789515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and Validity of the Snaith-Hamilton Pleasure Scale Clinician Administered Turkish Form.
    Gürcan A; Başar K; Şen ZD; Karakaşli AA
    Turk Psikiyatri Derg; 2022; 33(3):187-195. PubMed ID: 36148569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
    Kwan ATH; Le GH; Guo Z; Ceban F; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Ann Gen Psychiatry; 2024 Feb; 23(1):10. PubMed ID: 38424537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficiency of left superior frontal gyrus and the symptom features of major depressive disorder.
    Zhang L; Li Z; Lu X; Liu J; Ju Y; Dong Q; Sun J; Wang M; Liu B; Long J; Zhang Y; Xu Q; Li W; Liu X; Guo H; Lu G; Li L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):289-300. PubMed ID: 35545321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder.
    Rashidian H; Subramaniapillai M; Park C; Lipsitz O; Zuckerman H; Teopiz K; Cao B; Lee Y; Gill H; Ho R; Lin K; Rodrigues NB; Iacobucci M; Rosenblat JD; McIntyre RS; Mansur RB
    J Affect Disord; 2021 Mar; 282():448-453. PubMed ID: 33422821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
    McIntyre RS; Loft H; Christensen MC
    Neuropsychiatr Dis Treat; 2021; 17():575-585. PubMed ID: 33654400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Snaith-Hamilton Pleasure Scale (SHAPS): the dimension of anhedonia in Italian healthy sample.
    Martino I; Santangelo G; Moschella D; Marino L; Servidio R; Augimeri A; Costabile A; Capoderose G; Cerasa A
    Neurol Sci; 2018 Apr; 39(4):657-661. PubMed ID: 29383616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
    Watanabe K; Fujimoto S; Marumoto T; Kitagawa T; Ishida K; Nakajima T; Moriguchi Y; Fujikawa K; Inoue T
    Neuropsychiatr Dis Treat; 2022; 18():363-373. PubMed ID: 35221687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric evaluation of the Snaith-Hamilton pleasure scale in adult outpatients with major depressive disorder.
    Nakonezny PA; Carmody TJ; Morris DW; Kurian BT; Trivedi MH
    Int Clin Psychopharmacol; 2010 Nov; 25(6):328-33. PubMed ID: 20805756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
    Le GH; Kwan ATH; Guo Z; Wong S; Badulescu S; Gill H; Teopiz KM; Meshkat S; Ceban F; Phan L; Subramaniapillai M; Di Vincenzo JD; Rosenblat JD; Mansur RB; d'Andrea G; Ho R; Rhee TG; McIntyre RS
    Acta Neuropsychiatr; 2024 Apr; ():1-7. PubMed ID: 38605630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.